Skip to main content
. 2019 Mar 22;8(3):403. doi: 10.3390/jcm8030403

Table 2.

Patient characteristics of included studies.

Study No. Patients (n) Sex (n, %) Age (Years) Primary Tumour Location LM Size in cm (Median, Range) Non-Functional NETs (n, %) Resection of Primary Tumour (n, %) Resectable/Unresectable LM Uni-/Bilobar Metastases Extrahepatic Disease (n, %) WHO 2010 Grade
Male Female Pancreas (n, %) Small Bowel (n, %) Other/Unknown (n, %)
Watzka et al. [27] 204 111 (54) 93 (46) 58 ± 15 (60) * 58 (28) 73 (36) 73 (36) N/A 123 (60) 165 (81) Mixed N/A N/A All
Partelli et al. [26] 166 92 (55) 74 (45) N/A 166 0 0 LM resection 0.8 cm (0.3–1.7 cm); no resection at all 3.4 cm (1–7 cm) † 152 (92) 91 (55) Resectable Both N/A All
Citterio et al. [21] 139 67 (48) 72 (52) 56 (51–55) 36 (26) 66 (47) 37 (27) N/A 0 93 (67) Mixed N/A N/A 1–2
Du et al. [24] 130 69 (53) 61 (47) 49.0 ± 12.1 (N/A) * 85 (65) 7 [5] 38 (30) Mean 4.1 cm (range 3–15 cm) 100 (77) 68 (52) Mixed N/A N/A All
Bertani et al. [17] 121 66 (55) 58 (45) 54.6 ± 12.6 (54.5) * 121 (100) 0 0 N/A 29 (24) 63 (52) Unresectable N/A 28 (23) All
Boyar et al. [18] 114 61 (54) 83 (46) 57 (32–83) 111 (97) 0 3 [3] N/A 89 (78) 46 (40) Mixed N/A 51 (45) 1–2
Chamberlain et al. [19] 85 37 (44) 48 (56) 52 (20–79) 42 (49) 0 43 (51) N/A 49 (58) 36 (42) Mixed Both 45 (53) 1–2
Musunuru et al. [25] 48 30 (63) 18 (37) N/A 15 (31) 0 33 (69) Embolization 8.9 ± 6.1 cm; chemotherapy 3.7 ± 2.9 cm; any resection 4.5 ± 2.3 cm * N/A 12 (25) Unclear Both 0 N/A
Chen et al. [20] 38 24 (63) 14 (37) N/A 11 (29) 9 (24) 18 (47) N/A 9 (24) 12 (32) Mixed Bilobar 0 N/A
Dousset et al. [23] 34 18 (53) 17 (47) 49.5 (29–76) 17 (50) 9 (26) 8 (24) N/A 5 (15) 21 (62) Mixed Bilobar 0 N/A
Coppa 2001 et al. [22] 29 13 (45) 16 (55) N/A 0 0 29§ N/A N/A 11 (38) Mixed N/A 0 N/A

* mean ± SD (median); median (range); Age was reported for each subgroup separately; § 21 have a pancreatic or ileal origin, whilst 8 originated in the lung or rectum; N/A: not available.